Autocrine IFN-I inhibits isocitrate dehydrogenase in the TCA cycle of LPS-stimulated macrophages.
David P De Souza; Adrian Achuthan; Man Ks Lee; Katrina J Binger; Ming-Chin Lee; Sophia Davidson; Dedreia L Tull; Malcolm J McConville; Andrew D Cook; Andrew J Murphy; John A Hamilton; Andrew J Fleetwood
Abstract
Macrophage activation in response to LPS is coupled to profound metabolic changes, typified by accumulation of the TCA cycle intermediates citrate, itaconate, and succinate. We have identified that endogenous type I IFN controls the cellular citrate/α-ketoglutarate ratio and inhibits expression and activity of isocitrate dehydrogenase (IDH); and, via 13C-labeling studies, demonstrated that autocrine type I IFN controls carbon flow through IDH in LPS-activated macrophages. We also found that type I IFN-driven IL-10 contributes to inhibition of IDH activity and itaconate synthesis in LPS-stimulated macrophages. Our findings have identified the autocrine type I IFN pathway as being responsible for the inhibition of IDH in LPS-stimulated macrophages.
| Journal | THE JOURNAL OF CLINICAL INVESTIGATION |
| ISSN | 1558-8238 |
| Published | 01 Oct 2019 |
| Volume | 129 |
| Issue | 10 |
| Pages | 4239-4244 |
| DOI | 10.1172/JCI127597 |
| Type | Journal Article |
| Sponsorship | NHMRC: 1085752 |